DRUG · Mapped RxNorm record
Albuterol
Normalized identity: albuterolView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)
NCT01302587
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
AlbuterolDRUG · verified · RxNorm: albuterol
Sponsors & collaborators
Teva Branded Pharmaceutical Products R&D, Inc.lead sponsor
Mapped research locations
DallasTexas, United States1MiamiFlorida, United States1SeattleWashington, United States1San DiegoCalifornia, United States1PortlandOregon, United States1IndianapolisIndiana, United States1MinneapolisMinnesota, United States1OrangeCalifornia, United States1GreenvilleSouth Carolina, United States1RaleighNorth Carolina, United States1WichitaKansas, United States1TulsaOklahoma, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01302587 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.